Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series
In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior. Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagon...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2010-11, Vol.20 (22), p.6802-6807 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 6807 |
---|---|
container_issue | 22 |
container_start_page | 6802 |
container_title | Bioorganic & medicinal chemistry letters |
container_volume | 20 |
creator | Wanner, Jutta Chen, Lijing Lemoine, Rémy C. Kondru, Rama Jekle, Andreas Heilek, Gabrielle deRosier, André Ji, Changhua Berry, Pamela W. Rotstein, David M. |
description | In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior.
Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile. |
doi_str_mv | 10.1016/j.bmcl.2010.08.118 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_867749928</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0960894X10012540</els_id><sourcerecordid>867749928</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</originalsourceid><addsrcrecordid>eNqFkV9rFDEUxQdR7Fr9Aj5IXsSnXfNvZhLxpSy1FQpKVfAt3MncabPOJGuSLWy_mF_PjLvqm0Ig4eR3Tw45VfWc0RWjrHm9WXWTHVecFoGqFWPqQbVgspFLIWn9sFpQ3dCl0vLrSfUkpQ2lTFIpH1cnnKq65owvqh_ndzDuILvgSRgITK5HEnE7gsUJfU7EebJeX9cEfIab4F0qGpRFJgSfSA6FsBEhYTnk6HxylmwxluvOjS7vV-QjxEz4G_Lp7JqEbXaTuz-8CL4n21uIE9jwzXnM82gMgxvxVxpyG6YwhpuwKw_eg90XPWF0mJ5WjwYYEz477qfVl3fnn9eXy6sPF-_XZ1dLK1mbl3zQQJu61YOSg2AKG933Q98Bha5r2trWA1W6q2e567hg2grRdI0CaUXfanFavTr4lljfd5iymVyyOI7gsaQyqmlbqTVX_yXbWgtezEUh-YG0MaQUcTDb6CaIe8OomZs1GzM3a-ZmDVWmNFuGXhztd92E_Z-R31UW4OURgGRhHCJ469JfTghdczUbvT1wWL7tzmE0yTr0FnsX0WbTB_evHD8BC6TFJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>759323363</pqid></control><display><type>article</type><title>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wanner, Jutta ; Chen, Lijing ; Lemoine, Rémy C. ; Kondru, Rama ; Jekle, Andreas ; Heilek, Gabrielle ; deRosier, André ; Ji, Changhua ; Berry, Pamela W. ; Rotstein, David M.</creator><creatorcontrib>Wanner, Jutta ; Chen, Lijing ; Lemoine, Rémy C. ; Kondru, Rama ; Jekle, Andreas ; Heilek, Gabrielle ; deRosier, André ; Ji, Changhua ; Berry, Pamela W. ; Rotstein, David M.</creatorcontrib><description>In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior.
Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.</description><identifier>ISSN: 0960-894X</identifier><identifier>EISSN: 1464-3405</identifier><identifier>DOI: 10.1016/j.bmcl.2010.08.118</identifier><identifier>PMID: 20855212</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Amides - chemistry ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Aza Compounds - chemistry ; Aza Compounds - pharmacokinetics ; Aza Compounds - pharmacology ; Biological and medical sciences ; CCR5 antagonist ; CCR5 Receptor Antagonists ; HIV entry inhibition ; Medical sciences ; Permeability ; Pharmacology. Drug treatments ; Structure-Activity Relationship</subject><ispartof>Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6802-6807</ispartof><rights>2010 Elsevier Ltd</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2010 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</citedby><cites>FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0960894X10012540$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23395288$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20855212$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wanner, Jutta</creatorcontrib><creatorcontrib>Chen, Lijing</creatorcontrib><creatorcontrib>Lemoine, Rémy C.</creatorcontrib><creatorcontrib>Kondru, Rama</creatorcontrib><creatorcontrib>Jekle, Andreas</creatorcontrib><creatorcontrib>Heilek, Gabrielle</creatorcontrib><creatorcontrib>deRosier, André</creatorcontrib><creatorcontrib>Ji, Changhua</creatorcontrib><creatorcontrib>Berry, Pamela W.</creatorcontrib><creatorcontrib>Rotstein, David M.</creatorcontrib><title>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</title><title>Bioorganic & medicinal chemistry letters</title><addtitle>Bioorg Med Chem Lett</addtitle><description>In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior.
Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.</description><subject>Amides - chemistry</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Aza Compounds - chemistry</subject><subject>Aza Compounds - pharmacokinetics</subject><subject>Aza Compounds - pharmacology</subject><subject>Biological and medical sciences</subject><subject>CCR5 antagonist</subject><subject>CCR5 Receptor Antagonists</subject><subject>HIV entry inhibition</subject><subject>Medical sciences</subject><subject>Permeability</subject><subject>Pharmacology. Drug treatments</subject><subject>Structure-Activity Relationship</subject><issn>0960-894X</issn><issn>1464-3405</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkV9rFDEUxQdR7Fr9Aj5IXsSnXfNvZhLxpSy1FQpKVfAt3MncabPOJGuSLWy_mF_PjLvqm0Ig4eR3Tw45VfWc0RWjrHm9WXWTHVecFoGqFWPqQbVgspFLIWn9sFpQ3dCl0vLrSfUkpQ2lTFIpH1cnnKq65owvqh_ndzDuILvgSRgITK5HEnE7gsUJfU7EebJeX9cEfIab4F0qGpRFJgSfSA6FsBEhYTnk6HxylmwxluvOjS7vV-QjxEz4G_Lp7JqEbXaTuz-8CL4n21uIE9jwzXnM82gMgxvxVxpyG6YwhpuwKw_eg90XPWF0mJ5WjwYYEz477qfVl3fnn9eXy6sPF-_XZ1dLK1mbl3zQQJu61YOSg2AKG933Q98Bha5r2trWA1W6q2e567hg2grRdI0CaUXfanFavTr4lljfd5iymVyyOI7gsaQyqmlbqTVX_yXbWgtezEUh-YG0MaQUcTDb6CaIe8OomZs1GzM3a-ZmDVWmNFuGXhztd92E_Z-R31UW4OURgGRhHCJ469JfTghdczUbvT1wWL7tzmE0yTr0FnsX0WbTB_evHD8BC6TFJw</recordid><startdate>20101115</startdate><enddate>20101115</enddate><creator>Wanner, Jutta</creator><creator>Chen, Lijing</creator><creator>Lemoine, Rémy C.</creator><creator>Kondru, Rama</creator><creator>Jekle, Andreas</creator><creator>Heilek, Gabrielle</creator><creator>deRosier, André</creator><creator>Ji, Changhua</creator><creator>Berry, Pamela W.</creator><creator>Rotstein, David M.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20101115</creationdate><title>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</title><author>Wanner, Jutta ; Chen, Lijing ; Lemoine, Rémy C. ; Kondru, Rama ; Jekle, Andreas ; Heilek, Gabrielle ; deRosier, André ; Ji, Changhua ; Berry, Pamela W. ; Rotstein, David M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-2f9a06579f84f318e69ddfdba0abb675c5f089b569ddbb2319c336b68a4c3d793</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amides - chemistry</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Aza Compounds - chemistry</topic><topic>Aza Compounds - pharmacokinetics</topic><topic>Aza Compounds - pharmacology</topic><topic>Biological and medical sciences</topic><topic>CCR5 antagonist</topic><topic>CCR5 Receptor Antagonists</topic><topic>HIV entry inhibition</topic><topic>Medical sciences</topic><topic>Permeability</topic><topic>Pharmacology. Drug treatments</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wanner, Jutta</creatorcontrib><creatorcontrib>Chen, Lijing</creatorcontrib><creatorcontrib>Lemoine, Rémy C.</creatorcontrib><creatorcontrib>Kondru, Rama</creatorcontrib><creatorcontrib>Jekle, Andreas</creatorcontrib><creatorcontrib>Heilek, Gabrielle</creatorcontrib><creatorcontrib>deRosier, André</creatorcontrib><creatorcontrib>Ji, Changhua</creatorcontrib><creatorcontrib>Berry, Pamela W.</creatorcontrib><creatorcontrib>Rotstein, David M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic & medicinal chemistry letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wanner, Jutta</au><au>Chen, Lijing</au><au>Lemoine, Rémy C.</au><au>Kondru, Rama</au><au>Jekle, Andreas</au><au>Heilek, Gabrielle</au><au>deRosier, André</au><au>Ji, Changhua</au><au>Berry, Pamela W.</au><au>Rotstein, David M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series</atitle><jtitle>Bioorganic & medicinal chemistry letters</jtitle><addtitle>Bioorg Med Chem Lett</addtitle><date>2010-11-15</date><risdate>2010</risdate><volume>20</volume><issue>22</issue><spage>6802</spage><epage>6807</epage><pages>6802-6807</pages><issn>0960-894X</issn><eissn>1464-3405</eissn><abstract>In our CCR5 program, piperidine and azetidine amide replacements as means to improve intrinsic permeability were evaluated. This led to new series of potent CCR5 antagonists, with improved PK behavior.
Replacement of a secondary amide with a piperidine or azetidine moiety in a series of CCR5 antagonists led to the discovery of compounds with increased intrinsic permeability. This effort led to the identification of a potent CCR5 antagonist which exhibited an improved in vivo pharmacokinetic profile.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>20855212</pmid><doi>10.1016/j.bmcl.2010.08.118</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0960-894X |
ispartof | Bioorganic & medicinal chemistry letters, 2010-11, Vol.20 (22), p.6802-6807 |
issn | 0960-894X 1464-3405 |
language | eng |
recordid | cdi_proquest_miscellaneous_867749928 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Amides - chemistry Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Aza Compounds - chemistry Aza Compounds - pharmacokinetics Aza Compounds - pharmacology Biological and medical sciences CCR5 antagonist CCR5 Receptor Antagonists HIV entry inhibition Medical sciences Permeability Pharmacology. Drug treatments Structure-Activity Relationship |
title | Evaluation of amide replacements in CCR5 antagonists as a means to increase intrinsic permeability. Part 2: SAR optimization and pharmacokinetic profile of a homologous azacyle series |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T00%3A05%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evaluation%20of%20amide%20replacements%20in%20CCR5%20antagonists%20as%20a%20means%20to%20increase%20intrinsic%20permeability.%20Part%202:%20SAR%20optimization%20and%20pharmacokinetic%20profile%20of%20a%20homologous%20azacyle%20series&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry%20letters&rft.au=Wanner,%20Jutta&rft.date=2010-11-15&rft.volume=20&rft.issue=22&rft.spage=6802&rft.epage=6807&rft.pages=6802-6807&rft.issn=0960-894X&rft.eissn=1464-3405&rft_id=info:doi/10.1016/j.bmcl.2010.08.118&rft_dat=%3Cproquest_cross%3E867749928%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=759323363&rft_id=info:pmid/20855212&rft_els_id=S0960894X10012540&rfr_iscdi=true |